Indonesia approves J&J, Cansino Covid-19 vaccines for emergency use


JAKARTA, Sept 7 (Reuters): Indonesia has approved the single-dose Covid-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China's CanSino Biological Inc for emergency use, the country's food and drug agency said in a statement on Tuesday.

The number of Covid-19 cases in Indonesia rose by 7,201 within one day to 4,140,634, with the death toll adding by 683 to 137,156, the country's Health Ministry said on Tuesday (Sept 7).

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Anti-graft panel frees ex-PM Yingluck of any legal action
Mt Ruang eruption damages thousands of houses in North Sulawesi
Thailand plans for first post-coup Senate election, referendum
Bella Astillah has long known Sarah Yasmine is one of 11 women in relationship with husband Aliff Aziz
‘Audio deepfake’ of Marcos ordering military action against China prompts Manila to debunk clip
Singapore firms rethink workplace policies ahead of new flexi-work guidelines
Traditional Vietnamese ceremony honours ancient Hoang Sa flotilla
US regulator seeks US$5.3bil fine for Terraform Labs, Do Kwon
Straits Chinese eager for key role in 50th-anniversary celebration of Malaysia-China ties
Laos introduces new system to regulate foreign workers

Others Also Read